ArticleAnais brasileiros de dermatologia

Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study.

Burhan Engin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.